THE NUCLEAR FACTOR κB (NFκB) AND NOTCH SIGNALLING PATHWAYS AND BRCA1 MRNA EXPRESSION IN STAGE IV NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)

被引：0
|
作者：
Santarpia, Mariacarmela [1 ]
Sanchez-Ronco, Maria [2 ]
Magri, Ignacio
Angel Molina, Miguel
Viteri, Santiago
Costa, Carlota
Gasco, Amaya
Gonzalez-Cao, Maria
Mederos, Nuria
Salazar, Fernanda
Bertran-Alamillo, Jordi
Jimenez-Capitan, Ana
Altavilla, Giuseppe [1 ]
Benlloch, Susana
Yeste, Zaira
Aldeguer, Erika
Taron, Miquel [3 ]
Rosell, Rafael [3 ]
机构：
[1] Univ Hosp Policlin G Martino, Milan, Italy
[2] Univ Alcala de Henares, Alcala De Henares 99775, Spain
[3] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NFkB; Notch pathways; Non-Small-Cell Lung Cancer; BRCA1 mRNA expression;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S993 / S994
页数：2
相关论文
共 50 条
  • [41] Pilot SCAT trial: Spanish customized adjuvant chemotherapy (CT) based on BRCA1 mRNA expression levels (l) in resected stage II-IIIA non-small cell lung cancer (NSCLC) patients (p)
    Miguel Sanchez, Jose
    Cobo, Manuel
    Arrabal, Rafael
    Massuti, Bartomeu
    Rodriguez Paniagua, Jose Manuel
    Moran, Teresa
    Astudillo, Julio
    Jimenez, Ulpiano
    Wa Pun, Yat
    Aguiar Bujanda, David
    Freixenet, Jorge
    Gonzalez-Larriba, Jose-Luis
    Hernando-Trancho, Florentino
    Gomez-Codina, Jose
    Penalver, Juan-Carlos
    Martinez Banaclocha, Natividad
    Lopez-Vivanco, Guillermo
    Pac, Joaquin
    Taron, Miquel
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Correlation between BRCA1 and LMO4 mRNA expression levels in Erlotinib-treated non small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Costa, Carlota
    Gimenez-Capitan, Ana
    Benlloch, Susana
    Taron, Miguel
    Jimeno, Jose
    Viteri, Santiago
    Gasco, Amaya
    Camps, Carlos
    Carcereny, Enric
    Massuti, Bartomeu
    Rosell, Rafael
    CANCER RESEARCH, 2012, 72
  • [43] Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies
    Rosell, R.
    Molina, M. A.
    Costa, C.
    Taron, M.
    Bertran-Alamillo, J.
    Mayo, C.
    Benlloch, S.
    Moran, T.
    Cardenal, F.
    Porta, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] NFκB-IκBα Interaction: A Mechanism of Resistance to Cisplatin in Non Small Cell Lung Cancer (NSCLC)
    Heavey, Susan
    Barr, Martin
    Godwin, Peter
    Edwards, Connla
    O'Byrne, Ken
    Gately, Kathy
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [45] Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer
    Jiang, Li-Peng
    Zhu, Zhi-Tu
    He, Chun-Yan
    FUTURE ONCOLOGY, 2016, 12 (09) : 1105 - 1115
  • [46] Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations
    Rosell, Rafael
    Angel Molina, Miguel
    Costa, Carlota
    Simonetti, Sara
    Gimenez-Capitan, Ana
    Bertran-Alamillo, Jordi
    Mayo, Clara
    Moran, Teresa
    Mendez, Pedro
    Cardenal, Felipe
    Isla, Dolores
    Provencio, Mariano
    Cobo, Manuel
    Insa, Amelia
    Garcia-Campelo, Rosario
    Reguart, Noemi
    Majem, Margarita
    Viteri, Santiago
    Carcereny, Enric
    Porta, Ruth
    Massuti, Bartomeu
    Queralt, Cristina
    de Aguirre, Itziar
    Miguel Sanchez, Jose
    Sanchez-Ronco, Maria
    Luis Mate, Jose
    Ariza, Aurelio
    Benlloch, Susana
    Javier Sanchez, Jose
    Bivona, Trever G.
    Sawyers, Charles L.
    Taron, Miquel
    CLINICAL CANCER RESEARCH, 2011, 17 (05) : 1160 - 1168
  • [47] Effect of BRCA1 Haplotype on Survival of Non-Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
    Kim, Hong-Tae
    Lee, Jong-Eun
    Shin, Eun-Soon
    Yoo, Yeon-Kyeong
    Cho, Jae-Hwa
    Yun, Min-Hye
    Kim, Yeul-Hong
    Kim, Se-Kyu
    Kim, Hyun-Jung
    Jang, Tae-Won
    Kwak, Seung-Min
    Kim, Chul-Soo
    Ryu, Jeong-Seon
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5972 - 5979
  • [48] Management of Non-Small-Cell Lung Cancer (NSCLC) Stage III Patients in Central European Countries
    Zemanova, Milada
    Zbozinkova, Zuzana
    Pirker, Robert
    Jovanovic, Dragana
    Ceriman, Vesna
    Chaudhary, Subhash
    Richter, Igor
    Bogos, Krisztina
    Hollosi, Virag
    Petruelka, Lubog
    Kufa, Jiri
    Jakubikova, Lenka
    Purkalne, Gunta
    Tiefenbacher, Andreas
    Dieckmann, Karin
    Cernovska, Marketa
    Koubkova, Leona
    Vilasova, Zdefika
    Zemaitis, Marius
    Farkas, Attila
    Spasic, Jelena
    Kozlowski, Miroslaw
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S852 - S853
  • [49] Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China
    Au, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S308 - S308
  • [50] A single centre experience of first-line pembrolizumab in stage IV non-small-cell lung cancer (NSCLC)
    Denslow, R.
    Yarde, A.
    Brunner, C.
    Walther, J.
    Botten, J.
    Jankowska, P.
    LUNG CANCER, 2019, 127 : S35 - S35
12345